Drug Shortage Report for PROCTOFOAM HC
Report ID | 161599 |
Drug Identification Number | 00363014 |
Brand name | PROCTOFOAM HC |
Common or Proper name | PROCTOFOAM HC |
Company Name | DUCHESNAY INC |
Market Status | MARKETED |
Active Ingredient(s) | PRAMOXINE HYDROCHLORIDE HYDROCORTISONE ACETATE |
Strength(s) | 1% 1% |
Dosage form(s) | AEROSOL |
Route of administration | RECTAL RECTAL |
Packaging size | 22.4g |
ATC code | C05AA |
ATC description | AGENTS FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2022-05-31 |
Actual start date | 2022-05-31 |
Estimated end date | 2023-10-01 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-12-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 950 MICHELE-BOHEC BLVD BLAINVILLE, QUEBEC CANADA J7C 5E2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-12-06 | French | Compare |
v4 | 2022-12-06 | English | Compare |
v3 | 2022-06-01 | English | Compare |
v2 | 2022-05-31 | French | Compare |
v1 | 2022-05-31 | English | Compare |
Showing 1 to 5 of 5